ArticleVaccines2021
Prevalence and Potential Determinants of COVID-19 Vaccine Hesitancy and Resistance in Qatar: Results from a Nationally Representative Survey of Qatari Nationals and Migrants between December 2020 and January 2021.
Article in Vaccines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
38 citing papers in PubMed, 1 synthesis or guideline pooled it, 62 citations in OpenAlex.
- Systematic Review and Meta-Analysis of COVID-19 Vaccination Acceptance.Frontiers in medicine · 2021Pooled it
- Association between COVID-19 anxiety syndrome and COVID-19 vaccine hesitancy in the postpandemic era: a cross-sectional study in Hong Kong.BMC public health · 2025Article
- COVID-19 vaccine acceptance in the general population and under-resourced communities from high-income countries: realist review.BMJ open · 2024Review
- Exploring Factors Influencing COVID-19 Vaccine Hesitancy and Refusal: A Study in Italy during the Vaccine Rollout.International journal of environmental research and public health · 2024Article
- Predictors of COVID-19 vaccine acceptability among refugees and other migrant populations: A systematic scoping review.PloS one · 2024Article
- A scoping review of COVID-19 vaccine hesitancy: refusal rate, associated factors, and strategies to reduce.Frontiers in public health · 2024Article
- Defining drivers of under-immunization and vaccine hesitancy in refugee and migrant populations.Journal of travel medicine · 2023Article
- Hesitancy toward vaccination against COVID-19: A scoping review of prevalence and associated factors in the Arab world.Human vaccines & immunotherapeutics · 2023Article
- Prevalence of COVID-19 vaccine acceptance among migrant and refugee groups: A systematic review andVaccine: X · 2023Review
- Article
- Article
- COVID-19 Vaccine Acceptance and Hesitancy among Migrants, Refugees, and Foreign Workers: A Systematic Review and Meta-Analysis.Vaccines · 2023Review
- Article
- Access, acceptability, and uptake of the COVID-19 vaccine among global migrants: A rapid review.PloS one · 2023Review
- Incidence of SARS-CoV-2 Infection and Factors Associated With Complete COVID-19 Vaccine Uptake Among Migrant Origin Persons in Finland.International journal of public health · 2023Article
- COVID-19 vaccine hesitancy and acceptance among the public in the Gulf Cooperation Council countries: A review of the literature.Human vaccines & immunotherapeutics · 2022Review
- COVID-19 vaccine hesitancy and resistance in an urban Chinese population of Hong Kong: a cross-sectional study.Human vaccines & immunotherapeutics · 2022Article
- Community-level characteristics of COVID-19 vaccine hesitancy in England: A nationwide cross-sectional study.European journal of epidemiology · 2022Article
- Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors at 4 institutions in 2 countries.
Funding
Abstract
Global COVID-19 pandemic containment necessitates understanding the risk of hesitance or resistance to vaccine uptake in different populations. The Middle East and North Africa currently lack vital representative vaccine hesitancy data. We conducted the first representative national phone survey among the adult population of Qatar, between December 2020 and January 2021, to estimate the prevalence and identify potential determinants of vaccine willingness: acceptance (strongly agree), resistance (strongly disagree), and hesitance (somewhat agree, neutral, somewhat disagree). Bivariate and multinomial logistic regression models estimated associations between willingness groups and fifteen variables. In the total sample, 42.7% (95% CI: 39.5-46.1) were accepting, 45.2% (95% CI: 41.9-48.4) hesitant, and 12.1% (95% CI: 10.1-14.4) resistant. Vaccine resistant compared with hesistant and accepting groups reported no endorsement source will increase vaccine confidence (58.9% vs. 5.6% vs. 0.2%, respectively). Female gender, Arab ethnicity, migrant status/type, and vaccine side-effects concerns were associated with hesitancy and resistance. COVID-19 related bereavement, infection, and quarantine status were not significantly associated with any willingness group. Absence of or lack of concern about contracting the virus was solely associated with resistance. COVID-19 vaccine resistance, hesitance, and side-effects concerns are high in Qatar's population compared with those globally. Urgent public health engagement should focus on women, Qataris (non-migrants), and those of Arab ethnicity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.